Franklin Resources Inc Zai Lab LTD Transaction History

Franklin Resources Inc

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 10, 2023	BUY	$22.28 - $38.71 $36,828 - $63,987	1,653 Added 8.77%	20,495 $629,000
Q3 2022 Nov 14, 2022	BUY	$34.2 - $51.69 $270,590 - $408,971	7,912 Added 72.39%	18,842 $645,000
Q2 2022 Aug 11, 2022	SELL	$23.14 - $49.68 $38,019 - $81,624	-1,643 Reduced 13.07%	10,930 $379,000
Q1 2022 May 13, 2022	BUY	$27.77 - $64.4 $51,818 - $120,170	1,866 Added 17.43%	12,573 $553,000
Q4 2021 Feb 11, 2022	BUY	$54.9 - $105.21 $10,376 - $19,884	189 Added 1.8%	10,707 $673,000
Q3 2021 Nov 12, 2021	BUY	$105.0 - $178.37 $339,675 - $577,026	3,235 Added 44.42%	10,518 $1.11 Million
Q2 2021 Aug 13, 2021	SELL	$125.11 - $180.0 $30,777 - $44,280	-246 Reduced 3.27%	7,283 $1.29 Million
Q1 2021 May 13, 2021	BUY	$126.27 - $191.71 $308,351 - $468,155	2,442 Added 48.0%	7,529 $1 Million
Q4 2020 Feb 10, 2021	BUY	$81.94 - $135.34 $151,916 - $250,920	1,854 Added 57.35%	5,087 $689,000
Q3 2020 Nov 12, 2020	BUY	$73.3 - $89.48 $236,978 - $289,288	3,233 New	3,233 $269,000
Q1 2018 May 10, 2018	SELL	$20.05 - $26.96 $5.01 Million - $6.74 Million	-250,000 Closed	0 $0
Q3 2017 Nov 13, 2017	BUY	$27.0 - $31.11 $6.75 Million - $7.78 Million	250,000	250,000 $6.75 Million

121

46.7M

223K

588K

Ticker ZLAB
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 97,908,704
Market Cap $2.59B
Description
Zai Lab Limited develops and commercializes therapies to treat oncology, autoimmune disorders, infectious diseases, and neuroscience primarily in Mainland China and Hong Kong. The company's commercial products include Zejula, a once-daily small-molecule poly polymerase 1/2 inhibitor; Optune, a device that delivers tumor treating fields; NUZYRA f...

Get notified when there are updates to the investment portfolio of Franklin Resources Inc, based on Form 13F filings with the SEC.

Stay updated on Franklin Resources Inc with notifications on news.